G&RT Genetical and Retinal Treatment
LB13384BUndetermined Publication Date: 2026-08-06DR MADAH NAQSHBANDI
0 Cites 0 Cited by
Patent Information
- Application Number
- LB13384
- Authority / Receiving Office
- LB · LB
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2025-09-01
- Publication Date
- 2026-08-06
- Estimated Expiration
- 2045-09-01
Abstract
Blood lymph extracted from marine and / or river crabs supports the body's immunity and enhances its ability to fight certain intractable diseases such as iron overload and high blood pressure. Copper in the blood, thalassemia, and sclerosis Multiple sclerosis (MS) can be administered orally or by injection. Depending on the case, it also treats some genetic diseases and those resulting from aging. Retinitis pigmentosa, in particular Degeneration, (RETININIYIS PIGMENTOSA) Age-related macular degeneration Through injection, (MOCULAR DEGENERATION) With a diameter of 0.06 cc, according to the needle capacity 30 (NEEDLE GAUGE 30) It is injected directly into the vitreous body of the eye.
Need to check novelty before this filing date? Find Prior Art